Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Racial/Ethnic Differences Among Tumor-Infiltrating Lymphocytes in Breast Cancer Tumors

The Oncologist(2022)10.1093/oncolo/oyac239Source: DataRank Database

Racial/Ethnic Differences Among Tumor-Infiltrating Lymphocytes in Breast Cancer Tumors is a research paper published in The Oncologist (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.84)OA: goldTopics (34)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Anthony Silva ORCID,Alana Taniguchi,Christina Wiedmer,M. L. Martínez Fernández,Ian Pagano ORCID

Live enrichment

PubMed:36495151 OpenAlex:https://openalex.org/W4311024210

University of Hawaii Cancer Center

Grant: CA071789

National Institutes of Health

Grant: 3P30CA071789-14S2

Animal Carcinogenesis Core - Developmental Funds

FWCI

0.84

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

2026

goldLicense: CC BY

journalhttps://doi.org/10.1093/oncolo/oyac239

publisherhttps://doi.org/10.1093/oncolo/oyac239

publisherhttps://academic.oup.com/oncolo/article-pdf/28/2/116/49666394/oyac239.pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36495151

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9907033

Fields of Study

Cancer Immunotherapy and BiomarkersInflammatory Biomarkers in Disease PrognosisImmunotherapy and Immune Responses03 medical and health sciences0302 clinical medicine

MeSH Terms

Breast NeoplasmsEthnicityFemaleHumansLymphocytes, Tumor-InfiltratingErb-b2 Receptor Tyrosine KinasesReceptor, ErbB-2Neoadjuvant TherapyTumor Microenvironment

Keywords

MedicineBreast cancerTumor-infiltrating lymphocytesPacific islandersOncologyEthnic groupInternal medicineTumor microenvironmentCancerStage (stratigraphy)Multivariate analysisImmunotherapyPopulationLymphocytes, Tumor-InfiltratingEthnicityHumansFemaleBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesNeoadjuvant Therapy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being